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Abstract. Peripheral Arterial Disease (PAD) is the narrowing of peripheral blood vessels 
which prevalence is high in the elders. In 2010, it was estimated that 202 million people 
were suffering from PAD, most of which are in developing countries, especially the 
Southeast Asia region. Inflammation markers such as leukocyte and C-Reactive Protein 
(CRP) can predict the incidence of PAD but their use in determining prognosis remains 
unclear. Complications in PAD include amputation, increased cardiovascular events, and 
even death. Aim: This study aims to determine the relationship between leukocyte and CRP 
level on complications in PAD, in the forms of amputation, cardiovascular events, and 
mortality. Methods: This is a meta analysis study which uses online literature sourced from 
Pubmed, Science Direct, Cochrane, and Google Scholar. Results: Based on the data 
analysis, there is a significant relationship between CRP with the incidence of amputation 
(HR 1.24, 95%CI: 1.02-1.49, p=0.03) and hs-CRP with cardiovascular events (HR 1.33, 
95%CI: 1.10-1.60, p=0.003). Leukocyte on the other hand shows no significant relationship 
with the incidence of amputation (OR 1.10, 95%CI: 0.98-1.23, p=0.10) and mortality (OR 
1.14, 95%CI: 0.97-1.35, p=0.12) 
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1 Introduction 
PAD is defined as partial or total narrowing of blood vessels in peripheral arteries which is most 
often caused by atherosclerosis1. The location of the obstruction is often found in the lower 
extremities, affecting the popliteal artery, femoral artery and aortoiliac artery. There are several 
risk factors for PAD which include diabetes, hypertension, smoking, obesity, alcohol use, race, 
and Chronic Kidney Disease (CKD). Other important factors are increase in leukocyte, 
homocysteine, fibrinogen, and C-Reactive Protein levels 2.  
As many as 202 million people worldwide experienced PAD in 2010 and in the study A Global 
Atherothrombosis Assessment by American Society of Cardiology in 2006, it was found that 
the prevalence of PAD in Indonesia was 9.7%. A multi-country study of Peripheral Arterial 
Disease – Screening and Evaluation of diabetic patients in Asian Regions Characterized by 
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High Risk factors (PAD-SEARCH) said that there are 13.807 people affected by PAD for every 
one million people in Indonesia3. 
The role of inflammation is very important in the pathophysiology of PAD. Apart from being 
potential risk factors for PAD, inflammatory markers such as CRP and fibrinogen are also 
mentioned can be used as progressivity, functional capacity and complications markers in PAD 
patients4. Therefore, the authors are interested in conducting a study of the role of C-Reactive 
Protein and leukocytes in predicting complications in PAD. 
2 Methodology 
This is a meta-analysis study using online publication studies from google scholar, pubmed, 
chocrane, and science direct by using the search phrase “(((Leukocyte OR C-Reactive Protein) 
AND Peripheral Arterial Disease) AND Complication)”. The purpose of this study is to 
determine the relationship between leukocyte and CRP levels on complications in PAD. 
Inclusion criterias are publications done in the last 10 years, and have levels of CRP and 
leukocyte which can be calculated to determine the size of effect (Odds ratio/Hazard ratio). 
Review articles, comments, and study conducted in animals are excluded in this study.  
3 Result 
A total of 11 studies that meets the inclusion criteria with three discussing the relationship 
between CRP and amputation, three discussing hs-CRP and Cardiovascular events, four 
discussing leukocyte and amputation, two discussing leukocyte and mortality. There is an 















Figure 1 Selection of study used for meta-analysis. 
 
 
6057 studies in database 
49 potentially relevant studies 
11 relevant studies analyzed 
39 studies excluded : 
- 2 systematic review 
- 34 do not meet inclusion 
- 2 series review 
6008 studies excluded based on title 
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Table 1 Study Characteristics. 
 
Study Sample Endpoint HR 
(95% CI) 
Iida et al5. 
(2012) 




Shimamoto et al6. 
(2020) 
3505 Incidence of MALE (Major 
Adverse Limb Events) 
CRP ≥ 0.3 
1.44 
(1.20-1.74) 




Won et al7. 
(2014) 
101 Reintervention, major 




Otaki et al8. 
(2017) 




Urbonaviciene et al9.  
(2012) 








Skoglund et al10. 
(2014) 




    
Study Sample Endpoint OR 
(95% CI) 
Amaranto et al11. 
(2011) 
1773 Death, Amputation, TIA, 






Lin et al12.  
(2010) 
85 Major Amputation 2.26 
(0.45-11.3) 
 
Saskin et al13. 
(2016) 
123 Mortality and Amputation 1.00 
(0.99-1.01) 
Taşoğlu et al14. 
(2014) 
104 Amputation and all-cause death 1.10 
(0.90-1.2) 
Bhutta et al15. 
(2011) 
 
1021 Death within 2 years 1.02 
(0.95-1.09) 
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3.1 CRP and hs-CRP  
 
Figure 2 Forest plot A: CRP level and Amputation; Forest plot B: hs-CRP 
level and cardiovascular events. 
Analysis of leukocyte and complication of PAD can be seen in Figure 2. The results of four 
combined data used from three different studies shows that increased level of CRP have a 
significant relationship with the incidence of amputation (Forest plot A). The total hazard ratio 
obtained is 1.24 with 95% confidence interval between 1.02 and 1.49 (p=0.03).  
Hs-CRP level also correlates significantly with the incidence of cardiovascular events in PAD 
patients such as myocardial infarction, stroke, and all-cause cardiovascular death (Forest plot B) 
with total hazard ratio 1.33 and 95% confidence interval ranging from 1.10 to 1.60. 
3.2 Leukocyte  
Analysis of leukocyte and complication of PAD can be seen in Figure 3. In contrast to the two 
previous analyzes, no significant relationship between leukocyte level and amputation incidence 
in PAD patient (Forest plot C). Total odds ratio obtained from five different data is 1.10 with 
95% Confidence Interval ranging from 0.98 to 1.23 (p=0.10). 
There is also no significant relationship between leukocyte and mortality as one of the 
complication in PAD with total odds ratio 1.14 and 95% confidence interval ranging from 0.97 
to 1.35 (Forest plot D). 
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Figure 3 Forest plot C: Leukocyte level and amputation; Forest plot D: 
Leukocyte level and Mortality. 
4 Discussion 
Using three studies with 4012 total samples, we found a strong correlation between CRP level 
and the incidence of amputation (HR=1.24; 95%CI: 1.02-1.49, p=0.03). In Iida et al5 study, the 
mean CRP in the amputated group is 5.0±5.1mg/dL, higher than the non-amputated group with 
mean CRP 2.2±3.6mg/dL. Study by Shimamoto et al6 found 163 cases of amputation from a 
total of 2513 patients in the CRP<0.3 group compared to 94 cases in the CRP>0.3 group with a 
total of 993 samples. 
Mean hs-CRP is also higher in patients with cardiovascular event as complication in PAD. 
Otaki et al8 in his study concluded that the mean hs-CRP in the group with cardiovascular event 
is significantly higher than in the uncomplicated group. The mean hs-CRP in the cardiovascular 
event group is 2.33±0.65pg/mL compared to 1.94±0.54pg/mL in the non-cardiovascular event 
group. In the meta-analysis, the total hazard ratio for cardiovascular event is at 1.33 (95%CI: 
1.10-1.60, p=0.003). 
Leukocyte level in the complicated group is higher than the uncomplicated group but shows no 
significant correlation11,15. Total odds ratio found in the analysis is 1.10 (95%CI: 0.98-1.23, 
p=0.10) for the amputation outcome and 1.14 (95%CI: 0.97-1.35, p=0.12) for the mortality 
outcome.  
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5 Conclusion  
In this study there is a significant correlation between CRP level and the incidence of 
amputation (HR=1.24, 95%CI: 1.02-1.49, p=0.03). There is also a significant correlation 
between hs-CRP level and cardiovascular events in PAD (HR=1.33, 95%CI: 1.10-1.60, 
p=0.003). 
Unfortunately, we find  no significant correlation between leukocyte and amputation in PAD 
(OR=1.10, 95%CI: 0.98-1.23, p=0.10) There is also no significant correlation between 
leukocyte and mortality in PAD (OR=1.14, 95%CI: 0.97-1.35, p=0.12) 
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